Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Raw Materials: 2010-2025

Historic Raw Materials for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $89.1 million.

  • BIO-TECHNE's Raw Materials rose 14.93% to $94.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.0 million, marking a year-over-year increase of 14.93%. This contributed to the annual value of $89.1 million for FY2025, which is 12.22% up from last year.
  • BIO-TECHNE's Raw Materials amounted to $89.1 million in FY2025, which was up 12.22% from $79.4 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Raw Materials ranged from a high of $89.1 million in FY2025 and a low of $55.1 million during FY2021.
  • Moreover, its 3-year median value for Raw Materials was $84.6 million (2023), whereas its average is $84.3 million.
  • As far as peak fluctuations go, BIO-TECHNE's Raw Materials surged by 43.91% in 2022, and later decreased by 6.12% in 2024.
  • Over the past 5 years, BIO-TECHNE's Raw Materials (Yearly) stood at $55.1 million in 2021, then surged by 43.91% to $79.3 million in 2022, then increased by 6.63% to $84.6 million in 2023, then dropped by 6.12% to $79.4 million in 2024, then rose by 12.22% to $89.1 million in 2025.